G6 Materials Representative to Give Keynote Presentation at Graphene Korea 2021 International Conference

NEWS

05/25/2021

TSX-V: GGG, OTCQB: GPHBF

Dr. Polyakova, CEO of Graphene Laboratories Inc. to Address Attendees Regarding Commercialization of Graphene Oxide

Ronkonkoma, New York, USA - TheNewswire – May 25, 2021 - G6 Materials Corp. (“G6” or the “Company”) (TSXV: GGG, OTCQB: GPHBF),

a technology company creating value through the development of innovative graphene-based solutions, is pleased to announce that Dr. Elena Polyakova, the Chief Executive Officer of the Company’s wholly-owned subsidiary, Graphene Laboratories Inc., NY, USA (“GLI”) since 2009, will be a keynote presenter addressing the attendees of the Graphene Korea 2021 International Conference (the “Conference”) taking place as a virtual event from May 26-28, 2021. In her capacity as a representative of G6 during the Conference, Dr. Polyakova’s address at 1:30 PM GMT+2 on May 26, 2021 may include forward-looking information.

Dr. Polyakova’s presentation will be focused on the commercialization and competitive landscape of graphene oxide and other graphene-like materials. Graphene oxide is emerging as a material that, once considered to be a precursor for graphene production, is now finding applications due its unique chemical nature. Graphene oxide, unlike other graphene-like materials, has an ability to be further modified by a variety of chemical moieties, offering unique solutions for applications in water purification, soil remediation and waste management. Consequently, the commercialization of graphene oxide is an area of high strategic importance for the Company due to the revolutionary implications of, and significant potential value that stands to be created from, its applications.

For more information about the Conference, please visit www.setcor.org/conferences/graphene-korea-2021.

About Dr. Polyakova

Dr. Polyakova served as Co-Chief Executive Officer at the Company, formerly known as Graphene 3D Lab Inc., and for two and a half years as its Chief Operating Officer, during which time she was instrumental in bringing the first graphene filament to market. As a pioneer in the commercial graphene production market, Dr. Polyakova has grown GLI’s client base substantially over the past six years. Her expertise in 2D materials has been covered by prestigious news agencies such as BBC and Bloomberg. Dr. Polyakova has co-authored papers with Nobel and Kavli prize winners and members of the National Academy of Sciences. She previously was one of the first graphene researchers in the Flynn Group at Columbia University. Dr. Polyakova received a Ph.D. in Physical Chemistry from the University of Southern California and a Master's degree in Physical Chemistry from Moscow Institute of Physics and Technology.

About G6 Materials Corp.

G6 Materials Corp. is a technology company creating value through the development of innovative graphene-based solutions. Graphene Laboratories Inc., a wholly owned subsidiary of G6, sells a range of graphene-based products and other materials, including but not limited to conductive epoxies, fine chemicals, high performance composites and R&D materials, with numerous customers from among the Fortune 500 list of companies, as well as NASA and leading universities. Graphene Laboratories Inc. is developing other innovative products including graphene-enhanced air purifiers and it hopes to enter the global filtration market once all testing is complete and applicable government approvals are received.

G6 has identified new graphene-based applications to accelerate growth into the future. Accordingly, the Company has a valuable IP portfolio currently comprised of five granted patents and five patent applications filed. The Company’s management team and employees have a deep understanding of graphene technology based on decades of aggregate academic and commercial experience. Graphene Laboratories Inc., a wholly owned subsidiary of G6 located in Ronkonkoma, New York, has established its premium research laboratory and scalable production facility is equipped with advanced analytical and material processing equipment.

The Company’s e-commerce websites are listed below:

Conductive Epoxies

Adhesive materials distributed under the G6-EpoxyTM trade name and can be purchased at www.g6-epoxy.com

Fine Chemicals

ChemApproach is a worldwide supplier of a wide variety of unique chemical building blocks, which can be found at http://www.chemapproach.com

R&D Materials

Graphene Laboratories Inc. currently offers over 100 graphene and related products available at Graphene-Supermarket.com

Forward-Looking Information

This news release contains forward-looking statements within the meaning of the applicable securities legislation that is based on expectations, estimates and projections as at the date of this news release. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. “Forward-looking information” in this news release includes information about the potential for the Company’s long-term growth; the business goals and objectives of the Company, and other forward-looking information includes but is not limited to information concerning the intentions, plans and future actions of the parties to the transactions described herein and the terms thereon.

Risk factors that could cause actual results to differ materially from those described in such forward-looking information include, but are not limited to, the risks associated with outstanding litigation, if any; risks associated with adoption by industries of graphene-based products health and environmental factors affecting adoption of these technologies; the company may fail to obtain appropriate government approvals or accreditation related to the business’ operations and technological processes; the results of the tests being performed by an independent laboratory may be unsatisfactory and prevent the company from receiving government approvals and accreditations; the market conditions and demand for its product as well as the market prices of such products being developed by the company may change over time; reliance on key personnel; the potential for conflicts of interest among certain officers, directors or promoters with certain other projects; the absence of dividends; competition; dilution; the volatility of our common share price and volume; and tax consequences to U.S. shareholders.

The Company undertakes no obligation to revise or update any forward-looking information other than as required by law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.